Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit
Posted in General

Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit

Montréal startup’s backers include Theodorus, Eurêka, BKR Capital, Sandpiper, and ACET Capital. Clinical trials can be time-consuming, expensive, and suffer poor success rates. Using…

Continue Reading Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit
Spiderwort's CelluBridge product
Posted in General

Tissue engineering startup Spiderwort raises $17.1 million CAD to move to clinical trials

Spiderwort’s plant-based scaffolding can be used in regenerative medicine and tissue engineering. Ottawa-based biotech company Spiderwort has secured $17.1 million CAD ($13.2 million USD)…

Continue Reading Tissue engineering startup Spiderwort raises $17.1 million CAD to move to clinical trials